OUR STRATEGY

We invest in transformative therapeutics, medical device, and diagnostics companies with the potential to address major unmet medical needs

Therapeutics

We invest in next-generation precision therapeutics with a focus on genetic medicine and targeted therapies for molecularly-defined patient populations. We believe in a future where such therapies are the standard of care. Specifically, we are interested in:  

· Gene therapy, cell therapy, oligonucleotide therapeutics

· Immunology/immuno-oncology

· Neurodegenerative disease

· Targeted therapies for well-defined diseases

Medical Devices

We believe that advances in biotechnology, biomedical engineering, and computing are transforming what is possible in medical technology. The convergence of these fields is yielding smarter, safer, and more efficacious medical devices and biomaterials. Specifically, we are interested in:

· Novel biomaterials and tissue engineering

· Bio-active implants 

· Innovation in drug delivery

diagnostics

We invest in novel diagnostic approaches that combine state-of-the-art molecular and computational tools to generate actionable clinical insights. Specifically, we are interested in:

· Novel cellular or molecular diagnostics

· Liquid biopsy

· AI-supported diagnostics for disease prognosis and treatment guidance